SG Americas Securities LLC bought a new position in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 36,539 shares of the real estate investment trust's stock, valued at approximately $618,000.
Several other hedge funds and other institutional investors have also bought and sold shares of HR. Harbor Capital Advisors Inc. lifted its stake in Healthcare Realty Trust by 16.4% in the first quarter. Harbor Capital Advisors Inc. now owns 4,945 shares of the real estate investment trust's stock worth $84,000 after purchasing an additional 695 shares during the last quarter. Capital Investment Advisors LLC increased its holdings in shares of Healthcare Realty Trust by 18.5% in the first quarter. Capital Investment Advisors LLC now owns 556,293 shares of the real estate investment trust's stock worth $9,401,000 after buying an additional 86,970 shares during the period. UMB Bank n.a. lifted its stake in shares of Healthcare Realty Trust by 73.3% in the 1st quarter. UMB Bank n.a. now owns 3,024 shares of the real estate investment trust's stock valued at $51,000 after acquiring an additional 1,279 shares during the last quarter. Peak Financial Advisors LLC boosted its holdings in Healthcare Realty Trust by 6.8% during the 1st quarter. Peak Financial Advisors LLC now owns 11,413 shares of the real estate investment trust's stock valued at $193,000 after acquiring an additional 728 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Healthcare Realty Trust by 1,650.4% during the 1st quarter. GAMMA Investing LLC now owns 138,022 shares of the real estate investment trust's stock valued at $23,330,000 after acquiring an additional 130,137 shares during the period.
Analysts Set New Price Targets
Several analysts have weighed in on the company. Wells Fargo & Company lowered their price objective on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating for the company in a research report on Monday, June 2nd. Scotiabank lowered their price target on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a report on Tuesday, February 25th. Wall Street Zen cut shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Finally, Wedbush decreased their price objective on shares of Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Two analysts have rated the stock with a sell rating and four have assigned a hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $16.80.
Check Out Our Latest Stock Analysis on HR
Insider Activity at Healthcare Realty Trust
In other news, Director Thomas N. Bohjalian bought 2,500 shares of the stock in a transaction dated Tuesday, May 13th. The stock was bought at an average price of $14.71 per share, for a total transaction of $36,775.00. Following the purchase, the director now directly owns 56,502 shares in the company, valued at $831,144.42. This trade represents a 4.63% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.37% of the stock is owned by corporate insiders.
Healthcare Realty Trust Stock Up 0.6%
Shares of HR traded up $0.10 during mid-day trading on Wednesday, hitting $15.61. 4,415,612 shares of the company's stock traded hands, compared to its average volume of 3,116,315. The firm has a market capitalization of $5.49 billion, a P/E ratio of -14.32 and a beta of 0.88. The business's 50-day moving average price is $15.02 and its 200-day moving average price is $16.05. Healthcare Realty Trust Incorporated has a 1 year low of $14.09 and a 1 year high of $18.90.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share for the quarter, meeting the consensus estimate of $0.39. Healthcare Realty Trust had a negative net margin of 31.32% and a negative return on equity of 7.06%. The business had revenue of $288.86 million for the quarter, compared to analysts' expectations of $297.39 million. During the same quarter in the previous year, the business posted $0.39 earnings per share. The firm's revenue for the quarter was down 9.2% compared to the same quarter last year. Sell-side analysts anticipate that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current fiscal year.
Healthcare Realty Trust Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, May 23rd. Investors of record on Monday, May 12th were given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 7.94%. The ex-dividend date of this dividend was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio is currently -113.76%.
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
See Also

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.